- Where
- Work mode not stated: San Francisco Bay Area · USASan Francisco Bay Area
- Level
- Mid–Senior career, 5–10+ yrsMid–Senior5–10+ yrs
- Pay
- Not listed
- Apply by
- Rollingposted 22 Aug
- Hours and type
- Full-time
- Kind of work
- Research
- Added to CFI
- 22 August 2026
- Network
About the role
Analyses large single-cell in vivo Perturb-seq data across cardio-renal-metabolic disease programmes at Gordian. Turns the data into prioritised, testable hypotheses with disease-area leads.
Summary of the employer's page written by AI. Check the full listing before you apply.
Requires
Prior Perturb-seq or pooled perturbation-screen experience
This role's deadline has passed, so it is no longer on the board. See open roles.